The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 21, 2025
Filed:
Aug. 15, 2022
Applicant:
Santen Pharmaceutical Co., Ltd., Osaka, JP;
Inventors:
Yasuko Yamamoto, Ikoma, JP;
Takazumi Taniguchi, Ikoma, JP;
Assignee:
SANTEN PHARMACEUTICAL CO., LTD., Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/335 (2006.01); A61K 31/472 (2006.01); A61K 31/551 (2006.01); A61P 27/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/335 (2013.01); A61K 31/472 (2013.01); A61K 31/551 (2013.01); A61P 27/06 (2018.01);
Abstract
Described is a combination of a prophylactic or therapeutic agent for glaucoma or ocular hypertension, which is useful as a prophylactic or therapeutic agent for glaucoma or ocular hypertension. By combining sepetaprost and a Rho-associated coiled-coil containing protein kinase inhibitor(s), an intraocular pressure lowering action is enhanced as compared with the case where each drug is used alone. As the form of administration, they may be administered concomitantly or may be administered as a combination drug.